These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 19088694)

  • 1. Radiolabeled metaiodobenzylguanidine for imaging and therapy of neuroblastoma.
    Taggart D; Dubois S; Matthay KK
    Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):403-18. PubMed ID: 19088694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radio iodized metaiodobenzylguanidine (MIBG) in the treatment of neuroblastoma: modalities and indications].
    Défachelles AS; Cougnenc O; Carpentier P
    Bull Cancer; 2011 May; 98(5):559-69. PubMed ID: 21609890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.
    Matthay KK; Yanik G; Messina J; Quach A; Huberty J; Cheng SC; Veatch J; Goldsby R; Brophy P; Kersun LS; Hawkins RA; Maris JM
    J Clin Oncol; 2007 Mar; 25(9):1054-60. PubMed ID: 17369569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG.
    Matthay KK; Panina C; Huberty J; Price D; Glidden DV; Tang HR; Hawkins RA; Veatch J; Hasegawa B
    J Nucl Med; 2001 Nov; 42(11):1713-21. PubMed ID: 11696644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of tandem 131I-metaiodobenzylguanidine infusions in relapsed/refractory neuroblastoma.
    Johnson K; McGlynn B; Saggio J; Baniewicz D; Zhuang H; Maris JM; Mosse YP
    Pediatr Blood Cancer; 2011 Dec; 57(7):1124-9. PubMed ID: 21495159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma.
    Mastrangelo S; Tornesello A; Diociaiuti L; Riccardi R; Rufini V; Troncone L
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):69-71. PubMed ID: 9002754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial.
    Matthay KK; Weiss B; Villablanca JG; Maris JM; Yanik GA; Dubois SG; Stubbs J; Groshen S; Tsao-Wei D; Hawkins R; Jackson H; Goodarzian F; Daldrup-Link H; Panigrahy A; Towbin A; Shimada H; Barrett J; Lafrance N; Babich J
    J Nucl Med; 2012 Jul; 53(7):1155-63. PubMed ID: 22700000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 131I-Metaiodobenzylguanidine therapy in children with advanced neuroblastoma.
    DuBois SG; Matthay KK
    Q J Nucl Med Mol Imaging; 2013 Mar; 57(1):53-65. PubMed ID: 23474635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second malignancies in children with neuroblastoma after combined treatment with 131I-metaiodobenzylguanidine.
    Garaventa A; Gambini C; Villavecchia G; Di Cataldo A; Bertolazzi L; Pizzitola MR; De Bernardi B; Haupt R
    Cancer; 2003 Mar; 97(5):1332-8. PubMed ID: 12599242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 131I-metaiodobenzylguanidine therapy of neuroblastoma and other neuroendocrine tumors.
    Grünwald F; Ezziddin S
    Semin Nucl Med; 2010 Mar; 40(2):153-63. PubMed ID: 20113683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe oral mucositis after therapeutic administration of [131I]MIBG in a child with neuroblastoma.
    Dahllöf G; Borgström P; Lundell G; Jacobsson H; Kogner P
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Oct; 92(4):420-3. PubMed ID: 11598577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [131I meta-iodobenzylguanidine in combination with hyperbaric oxygen therapy in the treatment of prognostically high-risk forms of neuroblastoma].
    Stanková J; Kavan P; Krízová H; Hermanská E; Dosel P; Sázel M
    Cas Lek Cesk; 2001 Jan; 140(1):13-7. PubMed ID: 11242978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear medicine therapy of neuroblastoma.
    Hoefnagel CA
    Q J Nucl Med; 1999 Dec; 43(4):336-43. PubMed ID: 10731784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined use of chemotherapy and 131I-metaiodobenzylguanidine in the treatment of advanced-stage neuroblastoma.
    Sari O; Uğur O; Emir S; Akyüz C
    Turk J Pediatr; 2001; 43(1):29-33. PubMed ID: 11297155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma.
    DuBois SG; Matthay KK
    Nucl Med Biol; 2008 Aug; 35 Suppl 1(Suppl 1):S35-48. PubMed ID: 18707633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study.
    Modak S; Zanzonico P; Carrasquillo JA; Kushner BH; Kramer K; Cheung NK; Larson SM; Pandit-Taskar N
    J Nucl Med; 2016 Feb; 57(2):231-7. PubMed ID: 26742708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved radiation protection of the thyroid gland with thyroxine, methimazole, and potassium iodide during diagnostic and therapeutic use of radiolabeled metaiodobenzylguanidine in children with neuroblastoma.
    van Santen HM; de Kraker J; van Eck BL; de Vijlder JJ; Vulsma T
    Cancer; 2003 Jul; 98(2):389-96. PubMed ID: 12872361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma.
    DuBois SG; Messina J; Maris JM; Huberty J; Glidden DV; Veatch J; Charron M; Hawkins R; Matthay KK
    J Clin Oncol; 2004 Jun; 22(12):2452-60. PubMed ID: 15197208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age.
    de Kraker J; Hoefnagel KA; Verschuur AC; van Eck B; van Santen HM; Caron HN
    Eur J Cancer; 2008 Mar; 44(4):551-6. PubMed ID: 18267358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.
    Toporski J; Garkavij M; Tennvall J; Ora I; Gleisner KS; Dykes JH; Lenhoff S; Juliusson G; Scheding S; Turkiewicz D; Békássy AN
    Biol Blood Marrow Transplant; 2009 Sep; 15(9):1077-85. PubMed ID: 19660720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.